Intravenous immunoglobulin and rituximab in a treatment ‐refractory COVID‐19‐associated central nervous system vasculitis: A case report and literature review
In this study, we present the first case of treatment-refractory CNS vasculitis associated with COVID-19, which was treated successfully with intravenous immunoglobulin and rituximab. Second, we repo rt a review of COVID-19-related CNS vasculitis articles and applied treatment strategies published in English. To elucidate the mechanism of COVID-19-related CNS vasculitis, further research is needed.
Source: Clinical and Experimental Neuroimmunology - Category: Neurology Authors: Onur Anil Mutlu,
Merve İriş,
Nursena Erener,
Osman Kizilkiliç,
Civan Işlak,
Emire Seyahi,
Sabahattin Saip,
Uğur Uygunoğlu Tags: REVIEW ARTICLE Source Type: research
More News: Angiography | Brain | Cancer & Oncology | Coronavirus | COVID-19 | Headache | Migraine | MRI Scan | Neurology | Nursing | Respiratory Medicine | Rituxan | SARS | Study | Vasculitis